share_log

盟科药业(688373.SH):拟8000万美元增资美国全资子公司

Mengke Pharmaceutical (688373.SH): Plans to increase capital of a wholly-owned subsidiary in the US by 80 million US dollars

Gelonghui Finance ·  Dec 19, 2023 05:01

Gelonghui on December 19丨Mengke Pharmaceutical (688373.SH) announced that it plans to use its own capital to increase the capital of its wholly-owned subsidiary MiCurX Pharmaceuticals, Inc., in the US. The investment is a cash contribution, and the proposed investment amount is US$80 million.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment